Supplementary A. Sensitivity analysis on study population characteristics
To examine the impact of including only those patients with a Veterans Health Administration (VHA) healthcare priority group rating of 1 for our main study population, we expanded the study population to include patients with any VHA healthcare priority group rating. As compared to this expanded population, our study population had higher annual outpatient utilization during the sixyear study period (12 vs. 9 outpatient visits per year, standardized difference (SD)>10) and differed slightly by the presence of two comorbidities, diabetes (19.9% vs. 15.7%, SD>10) and depression (38.1% vs. 23.8%, SD>10; Supplementary Table A) . Overall, though, the two populations were very similar in terms of demographic and clinical characteristics. That we found a more complete recording of healthcare activities for those with a healthcare priority group rating of 1 is precisely the reason this criterion was applied to our study population.
In a separate analysis, we identified CDI among Veterans using linked VHA electronic medical record and Centers for Medicare and Medicaid Services (Medicare) administrative claims datasets, as Veterans 65 years or older are eligible for Medicare and those less than 65 years may be eligible due to disability or end stage renal disease, offering a more complete accounting of both VHA and non-VHA healthcare utilization and its effect on measuring incidence. CDI episodes were identified by the presence of an International Classification of Disease, 9th edition (ICD-9-CM) diagnosis code 008.45 (intestinal infection due to Clostridioides difficile (C. diff)); CDI antibiotic treatment (non-topical metronidazole, oral vancomycin, or fidaxomicin) within 14 days of a CDI diagnosis code and/or C. diff test (VHA: a C. diff-specific test name and/or description; Medicare: HCPC code 87493, 87324, 87803, 3520F, 87075, 87081, 87449, or 87230) ; and/or a C. diff test within 14 days of a CDI diagnosis code and/or CDI antibiotic treatment.
A total of 50,936 CDI episodes were identified among Veterans with at least one VHA healthcare encounter during 2012. For those aged 65 years and older, the majority of these episodes, 55.1% (24,555), were identified solely from Medicare data, while 43.1% (19,209) were identified solely from VHA data and 1.7% (766) were found by indicators in both data sources. Conversely, for those less than 65 years of age, the majority of these episodes, 72.5% (6,406), were identified solely from VHA data, while 26.2% (1,678) were identified solely from Medicare data and 1.3% (82) were found by indicators in both data sources. CDI incidence was found to be lowest for all Veterans using VHA data alone and highest for Veterans with a healthcare priority group rating of 1 using the integrated VHA EMR-Medicare linked data, regardless of age group ( Supplementary Table B ). Incidence rose across both variables for all age groups: including only those with a healthcare priority group rating of 1 and integration of Medicare data; however, the frequency of CDI episodes identified in Medicare data increased substantially across age groups. These findings underscore the imperative for including Medicare data for research on the population aged 65 years and older, while for epidemiological assessments of those less than 65 years of age in VHA, restricting to those with a healthcare priority group rating of 1 provides the most comprehensive data. 
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